XML 43 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jan. 31, 2013
Jan. 31, 2012
Operating activities    
Net loss $ (40,608) $ (17,962)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 7,473 2,247
Stock-based expense 19,072 5,758
Bad debt expense 1,643 925
Excess tax benefit related to stock-based compensation (365)  
Changes in operating assets and liabilities:    
Accounts receivable (10,581) (8,394)
Prepaid expenses and other current assets 257 529
Other non-current assets 1,161 (361)
Accounts payable 521 2,005
Accrued expenses and other current liabilities 7,027 5,125
Deferred revenue 4,647 9,971
Other liabilities, long-term (2,952) 1
Net cash used in operating activities (12,705) (156)
Investing activities    
Acquisitions, net of cash acquired, and purchase of intangible asset (60,750)  
Purchases of property, equipment and capitalized internal-use software development costs (8,004) (3,806)
Purchases of short-term investments (74,578)  
Proceeds from sale of short-term investments 43,783  
Increase in restricted cash   (250)
Net cash used in investing activities (99,549) (4,056)
Financing activities    
Payments of initial stock offering costs   (938)
Proceeds received from follow-on stock offering, net of costs 51,943  
Proceeds from exercise of stock options 9,470 2,478
Excess tax benefit related to stock-based compensation 365  
Net cash provided by financing activities 61,778 1,540
Effect of exchange rate fluctuations on cash and cash equivalents (46) (73)
Net decrease in cash and cash equivalents (50,522) (2,745)
Cash and cash equivalents at beginning of period 74,367 15,050
Cash and cash equivalents at end of period 23,845 12,305
Supplemental disclosure of other cash flow information:    
Cash paid for income taxes 236 105
Supplemental disclosure of non-cash investing and financing activities:    
Accretion of redeemable convertible preferred stock   35
Accrued stock offering costs   1,600
Issuance of stock for acquisition $ 125,497